WASHINGTON, D.C. – Farragut Capital Partners, Inc. is pleased to announce the closing of an investment in Amglo Kemlite Laboratories, Inc. (“Amglo”).  Farragut invested subordinated debt and made an equity co-investment to support the acquisition of Amglo by NewCastle Partners, LLC.  The Amglo transaction marks the fifth investment of the firm’s second SBIC Fund.

WASHINGTON, D.C. – Farragut Capital Partners, Inc. (“Farragut”) is pleased to announce the closing of an investment in Graco Supply Co., a portfolio company of CM Equity Partners.  Farragut invested subordinated debt to support Graco’s acquisition of E.V. Roberts and partnered with SPP Mezzanine Investors on the transaction.

WASHINGTON, DC. – Farragut Capital Partners, Inc. (“Farragut”) is pleased to announce the closing of an investment in Crestcom International Holdings, LLC (“Crestcom” or “the Company”).  Farragut invested subordinated debt and preferred equity to refinance existing debt and support growth initiatives at the Company.  The Crestcom transaction marks the second investment of the firm’s latest investment vehicle.

WASHINGTON, D.C. - Farragut Capital Partners, Inc. (“Farragut”) is pleased to announce two exciting milestones: the addition of Connor Davis to its investment team and the closing of an investment in Phelps Industries, LLC. Connor joined Farragut in January as an Associate and will support investment activity of Farragut's second fund, Farragut SBIC Fund II, LP. Phelps marks the first investment of the new fund. 

WASHINGTON, D.C. – Farragut Capital Partners, Inc. (“Farragut”) is pleased to announce the closing of a $4.5 million subordinated debt investment in Wisconsin Pharmacal Co., LLC (the “Company”) in partnership with management.  Proceeds from the transaction were used to refinance existing debt. 

Farragut Capital Partners, LLC is pleased to report that it has made its third investment of the year and has two realizations to date in 2018.